Department of Quality and Safety, Children's Hospital & Clinics of Minnesota, 2525 Chicago Avenue South, Minneapolis, MN 55404, USA.
Pediatrics. 2012 Jan;129(1):e165-73. doi: 10.1542/peds.2011-0566. Epub 2011 Dec 5.
Although reports of reduced nosocomial infections (NI) in very low birth weight infants have been published, the durability of these gains and changes in secondary outcomes, and clinical practices have less often been published.
This was a retrospective, observational study of NI reduction in very low birth weight infants at two hospital campuses. The intervention began in 2005 with our renewed quality improvement efforts to reduce NI. We compared outcomes before (2000-2005) and after (2006-2009) the intervention by using univariate and multiple regression analyses.
We reduced NI by 50% comparing 2000-2005 to 2006-2009 (23.6% vs 11.6%, P < .001). Adjusting for covariates, the odds ratio for NI was 0.33 (confidence interval, 0.26 - 0.42, P < .001) in the more recent era. NI were lower even in infants with birth weight 501-1000 grams (odds ratio = 0.38, confidence interval, 0.29 - 0.51, P < .001). We also reduced bronchopulmonary dysplasia (30.2% vs 25.5%, P = .001), median days to regain birth weight (9 vs 8, P = .04), percutaneously placed central venous catheter use (54.8% vs 43.9%, P = .002), median antibiotic days (8 vs 6, P = .003), median total central line days (16 vs 15, P = .01), and median ventilator days (7 vs 5, P = .01). We sustained improvements for three years.
Quality improvement efforts were associated with sustained reductions in NI, bronchopulmonary dysplasia, antibiotic use, central line use, and ventilator days.
尽管已有报道称极低出生体重儿(VLBW)的医院感染(NI)有所减少,但这些成果的持久性以及次要结局和临床实践的变化却鲜少被报道。
这是一项针对两家医院院区的 VLBW 患儿中减少 NI 的回顾性观察性研究。干预措施始于 2005 年,我们重新开展了质量改进工作以减少 NI。我们通过单变量和多变量回归分析比较了干预前(2000-2005 年)和干预后(2006-2009 年)的结果。
与 2000-2005 年相比,2006-2009 年 NI 减少了 50%(23.6%比 11.6%,P<.001)。在调整了混杂因素后,近期时代 NI 的比值比为 0.33(95%置信区间,0.26-0.42,P<.001)。即使是出生体重为 501-1000 克的婴儿,NI 也更低(比值比=0.38,95%置信区间,0.29-0.51,P<.001)。我们还减少了支气管肺发育不良(30.2%比 25.5%,P=0.001)、恢复出生体重的中位天数(9 天比 8 天,P=0.04)、经皮放置中心静脉导管的使用率(54.8%比 43.9%,P=0.002)、抗生素使用天数(8 天比 6 天,P=0.003)、总中心静脉置管天数(16 天比 15 天,P=0.01)和呼吸机使用天数(7 天比 5 天,P=0.01)。我们的改善成果持续了三年。
质量改进工作与 NI、支气管肺发育不良、抗生素使用、中心静脉置管使用和呼吸机使用天数的持续减少有关。